Brandes Investment Partners LP reduced its position in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 55.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 661,970 shares of the company's stock after selling 822,769 shares during the period. Brandes Investment Partners LP owned about 1.63% of Phibro Animal Health worth $13,901,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Quantbot Technologies LP acquired a new stake in Phibro Animal Health in the 3rd quarter valued at about $70,000. New York State Teachers Retirement System lifted its stake in Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after purchasing an additional 775 shares during the last quarter. Amundi lifted its stake in Phibro Animal Health by 185.5% in the 4th quarter. Amundi now owns 9,855 shares of the company's stock valued at $212,000 after purchasing an additional 6,403 shares during the last quarter. Zacks Investment Management acquired a new stake in Phibro Animal Health during the third quarter worth approximately $274,000. Finally, SG Americas Securities LLC lifted its position in Phibro Animal Health by 7.4% during the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock worth $276,000 after acquiring an additional 906 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several equities research analysts have issued reports on PAHC shares. Barclays raised their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research report on Monday, February 10th. Morgan Stanley raised their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a research report on Tuesday, December 17th. Finally, StockNews.com upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Saturday, March 15th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $21.00.
Get Our Latest Stock Analysis on PAHC
Phibro Animal Health Stock Performance
Shares of PAHC traded down $0.47 during mid-day trading on Thursday, hitting $21.81. 134,202 shares of the company's stock were exchanged, compared to its average volume of 176,415. Phibro Animal Health Co. has a 52 week low of $12.07 and a 52 week high of $26.55. The stock's 50-day simple moving average is $22.63 and its 200-day simple moving average is $22.59. The firm has a market cap of $883.37 million, a price-to-earnings ratio of 45.44, a price-to-earnings-growth ratio of 0.45 and a beta of 0.58. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, equities research analysts expect that Phibro Animal Health Co. will post 1.95 EPS for the current year.
Phibro Animal Health Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 2.20%. Phibro Animal Health's dividend payout ratio is presently 100.00%.
About Phibro Animal Health
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Articles
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
